Kiniksa Pharmaceuticals International, plc
Develops immune-modulating therapies for autoimmune and cardiovascular diseases.
KNSA | US
Overview
Corporate Details
- ISIN(s):
- BMG5269C1010
- LEI:
- Country:
- United States of America
- Address:
- 23 OLD BOND STREET, FLOOR 3, LONDON
- Website:
- https://www.kiniksa.com/
- Sector:
- Manufacturing
Description
Kiniksa Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing therapeutic medicines for patients with debilitating diseases and significant unmet medical needs. The company's portfolio is centered on immune-modulating assets. Its commercial product, ARCALYST® (rilonacept), is an interleukin-1α and interleukin-1β cytokine trap for the treatment of recurrent pericarditis and other autoinflammatory diseases. Kiniksa's clinical development pipeline includes investigational therapies such as KPL-387, a monoclonal antibody IL-1 receptor antagonist also being evaluated for recurrent pericarditis. The company concentrates its efforts in therapeutic areas including cardiovascular and autoimmune diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Kiniksa Pharmaceuticals International, plc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Kiniksa Pharmaceuticals International, plc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Kiniksa Pharmaceuticals International, plc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
